Abaloparatide Patent Invalidity Search

PROBLEM STATEMENT

The Client’s Challenge

A client requested an invalidity search involving a patent related to an abaloparatide drug formulation. The claimed subject matter involved specific formulation characteristics, including the presence of beta-Asp10 related peptide content, defined pH conditions, concentration parameters and analytical evaluation using HPLC and/or UPLC methods after controlled storage conditions.

The investigation required determining whether the claimed elements represented previously disclosed technical knowledge or whether relevant teachings existed across earlier pharmaceutical and peptide research.

The investigation focused on identifying disclosures related to:

- Abaloparatide and related peptide analogs
- Parathyroid hormone-related protein (PTHrP) derivatives
- Beta-Asp10 formation and peptide modifications
- Buffer-based pharmaceutical formulations
- Stability assessment methodologies
- HPLC/UPLC-based analytical detection approaches

CLIENT’S OBJECTIVE

Assess the validity of a patent related to an abaloparatide drug formulation by identifying prior art disclosures capable of challenging the claimed technical features.

Traditional Invalidity Search Approach

The initial investigation followed a conventional pharmaceutical prior art search methodology. The search process examined patent literature, scientific literature, chemical and drug databases.

The investigation used multiple search approaches, including:

Conventional Investigation Strategy

Keyword and synonym searching

IPC/CPC classification searching

Assignee-based searching

Inventor-based searching

Citation and similar-document analysis

Traditional Prior Art Search Workflow

Patent Landscape Analysis

Review patent scope and claims
Analyze prosecution history documents
Identify critical claim elements

Keyword-Based Searching

Define technical terms and synonyms
Apply Boolean search strategies
Explore related peptide terminology

Classification-Based Searching

Search IPC and CPC classes
Identify related technology domains
Expand relevant patent categories

Prior Art Screening

Review abstracts and claims
Evaluate technical relevance
Exclude unrelated disclosures

Technical Disclosure Review

Analyze detailed patent descriptions
Extract supporting technical teachings
Identify experimental embodiments

Reference Correlation Mapping

Map claim elements across references
Identify complementary technical disclosures
Assess combined prior art teachings

7. Invalidity Position Assessment

Evaluate novelty and inventiveness
Analyze reference combinations
Develop evidence-based conclusions

Identified multiple prior art references collectively disclosing key abaloparatide formulation elements and supporting a strengthened invalidity assessment.

Although the initial prior art search identified several relevant disclosures related to abaloparatide, peptide analogs, pharmaceutical formulations and analytical characterization methods, the investigation encountered few limitations.

Limitations of Traditional Approaches

Relevant peptide structure disclosures were often separated from formulation-specific teachings.
Pharmaceutical composition details were disclosed independently from analytical evaluation methods.
Stability assessment conditions and degradation analysis approaches appeared across different technical references.
Direct searches using abaloparatide-specific terminology provided limited coverage due to variations in scientific terminology and peptide nomenclature.
Multiple references were required to reconstruct the technical relationship between the claimed features.

As a result, a conventional single-reference search approach was insufficient to fully evaluate the strength of the patent claims.

Start a Conversation →

Wissen’s Out-of-the-Box Approach:

Expanding Beyond Direct Abaloparatide Disclosures

Recognizing the limitations of direct keyword-based searching, the investigation evolved from searching for identical disclosures toward identifying interconnected technical teachings across related pharmaceutical domains.
The strategy focused on understanding the technical foundation of the claimed invention rather than limiting the search to exact terminology. This involved examining:

Related peptide analog technologies
Parathyroid hormone-related protein (PTHrP) research
Pharmaceutical formulation approaches

Identifying Related Technical Pathways

A specialized search approach was developed to identify references beyond direct abaloparatide disclosures.

The investigation expanded into structurally and functionally related peptide technologies, including PTHrP analogs, parathyroid hormone-related peptides, peptide substitution strategies, aspartic acid modifications and formulation stabilization approaches.

Our Methodology

Patent Scope & Claim Analysis

Review patent claims and scope
Analyze prosecution history documents
Identify critical technical elements

Technical Feature Identification

Define peptide-related claim features
Identify formulation parameters
Determine analytical testing requirements

Multi-Database Prior Art Search

Search patent and scientific databases
Apply keyword and classification searches
Explore citation and similarity results

Analog & Structure-Based Searching

Search related PTHrP analogs
Explore peptide structural modifications
Conduct specialized STN searches

Pharmaceutical Disclosure Analysis

Examine formulation and stability teachings
Analyze peptide modification disclosures
Review HPLC and UPLC methods

Multi-Reference Claim Mapping

Map references against claim elements
Identify complementary technical disclosures
Correlate overlapping pharmaceutical teachings

Invalidity Position Development

Assess combined prior art teachings
Evaluate claim element coverage
Develop evidence-based invalidity position

Evidence Collection & Validation

To establish the relevance and reliability of identified prior art, the investigation performed detailed technical evaluation of each reference. The evidence review focused on extracting:

Specific technical disclosures

Formulation details

Peptide modification information

Analytical testing methodologies

Stability-related teachings

Technical Challenges Addressed Through Pharmaceutical Prior Art Analysis

Challenge 1: Identifying Prior Art for a Multi-Component Pharmaceutical Claim

The primary challenge was identifying prior art that disclosed the combination of technical elements associated with the abaloparatide formulation claims.

The claimed subject matter incorporated multiple parameters, including peptide composition, beta-Asp10 content, formulation characteristics, storage conditions, and analytical detection methods. However, these elements were not consistently disclosed together within a single prior art reference.

Solution

A claim-element-driven analysis was performed to deconstruct the claimed invention into individual technical components and evaluate each element against available prior art disclosures. The investigation identified multiple references that disclosed individual aspects of the claimed technology.

The analysis revealed:

PTHrP peptide disclosures
Abaloparatide analog modifications
Buffered formulation approaches
Peptide degradation analysis methods

These findings demonstrated that significant technical elements of the claimed invention were already represented within existing pharmaceutical literature.

Challenge 2: Establishing Relationships Between Fragmented Prior Art References

The identified prior art references disclosed different portions of the claimed invention. The challenge was determining whether these references could be technically correlated and whether their combined teachings addressed the claimed subject matter.

A simple collection of references was insufficient; the investigation required understanding the scientific relationship between each disclosure.

Solution

A structured reference-mapping approach was applied to evaluate the contribution of each prior art document.

The analysis:

Compared technical teachings
Identified overlapping concepts
Evaluated chemistry-formulation consistency
Assessed analytical method alignment

The investigation identified nine relevant references, with each contributing one or more technical aspects associated with the claimed invention.

Results & Business Impact

The investigation successfully identified nine technically relevant prior art references that collectively addressed significant aspects of the abaloparatide drug formulation claims.

Key Outcomes

Identified prior art covering peptide structures, formulation strategies, and analytical methods related to abaloparatide.
Established technical connections between previously fragmented pharmaceutical disclosures.
Mapped relevant references against key claim elements.
Identified potential weaknesses in the claimed combination of technical features.
Developed a stronger evidence foundation for invalidity assessment.

Strategic Business Impact

Pharmaceutical patent challenges often involve inventions that combine multiple established scientific concepts into a single claimed formulation. A conventional search approach focused only on identical disclosures may overlook important prior art relationships.

By combining:

Patent prosecution analysis
Pharmaceutical domain searching
Peptide chemistry investigation
Formulation analysis
Analytical method evaluation

The investigation provided a more comprehensive assessment of the patent landscape.

The investigation demonstrated the importance of connecting scientific disclosures across multiple research domains when evaluating complex pharmaceutical patents.

Conclusion & Implications

This investigation demonstrates the complexity of evaluating pharmaceutical patent validity where relevant prior art may be distributed across multiple scientific disciplines. The challenge was not simply locating references related to abaloparatide, but determining how existing disclosures across peptide analogs, formulation technologies and analytical methods connected to the claimed invention. Through a structured investigation approach, nine relevant prior art references were identified and analyzed for their contribution toward the claimed technical features. The investigation demonstrated how a broader technical perspective can uncover relationships between fragmented disclosures and provide deeper insight into the strength of pharmaceutical patent claims. The project reinforced several important principles for pharmaceutical invalidity research:

Evaluate individual claim elements

Explore beyond patent terminology

Analyze scientific reference relationships

Combine expertise with mapping

Can Pharmaceutical Prior Art Mapping Reveal Overlooked Pathways to Challenge an Abaloparatide Patent?